New pill targets Tough-to-Treat cancers in early trial
NCT ID NCT05735080
Summary
This early-stage study is testing a new oral medication called INX-315 in people with advanced cancers that have spread or stopped responding to standard treatments. It aims to find a safe dose and see if the drug can help control cancers like certain types of breast and ovarian cancer. The study will test INX-315 alone and in combination with other cancer drugs.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Dana-Farber Cancer Institute
RECRUITINGBoston, Massachusetts, 02215, United States
Contact
Contact Email: •••••@•••••
-
Duke Cancer Center/ DUMC
RECRUITINGDurham, North Carolina, 27705, United States
Contact
-
Emory Winship Cancer Institute
RECRUITINGAtlanta, Georgia, 30322, United States
Contact
-
Florida Cancer Specialists
RECRUITINGLake Mary, Florida, 32746, United States
Contact Email: •••••@•••••
Contact
-
Fort Wayne Medical Oncology and Hematology
RECRUITINGFort Wayne, Indiana, 46804, United States
Contact Email: •••••@•••••
Contact
-
Gabrail Cancer Research Center
RECRUITINGCanton, Ohio, 44718, United States
Contact Email: •••••@•••••
Contact
-
Georgia Cancer Center at Augusta University
RECRUITINGAugusta, Georgia, 30912, United States
Contact Email: •••••@•••••
-
Karmanos Cancer Institute
RECRUITINGDetroit, Michigan, 48201, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Levine Cancer Institute (LCI)- Atrium Health
RECRUITINGCharlotte, North Carolina, 28204, United States
Contact
-
Mater Hospital
RECRUITINGSouth Brisbane, 4101, Australia
Contact
-
Next Oncology
RECRUITINGDallas, Texas, 75039, United States
Contact Email: •••••@•••••
Contact
-
Next Oncology
RECRUITINGHouston, Texas, 77054, United States
Contact Email: •••••@•••••
Contact
-
Northwest Medical Specialties, PLLC
RECRUITINGTacoma, Washington, 98405, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Oncology Consultants
NOT_YET_RECRUITINGHouston, Texas, 77030, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Peter MacCallum Cancer Center
RECRUITINGParkville, Victoria, 3052, Australia
Contact
Contact Email: •••••@•••••
-
Roswell Park Cancer Institute
RECRUITINGBuffalo, New York, 14263, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
UTSW Medical Center
RECRUITINGDallas, Texas, 75390, United States
Contact
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.